Brief: Hemcheck Sweden Q2 Oper Revenue Up At SEK 324,505
Aug 31 (Reuters) - Hemcheck Sweden AB HEMC.ST :
* Q2 OPERATING REVENUE SEK 324,505 VERSUS SEK 53,975 YEAR
AGO
* Q2 REVENUE SEK 324,505 VERSUS SEK 53,975 MILLION YEAR AGO
Source text for Eikon: ID:nWkr9Pc1Xb
Further company coverage: HEMC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln